Pharma Journalist -

GC Biopharma and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA)-based therapeutics, announced that they…
Read More...

Plexium, Inc. (Plexium) and AbbVie have entered into an exclusive strategic collaboration to develop and commercialize novel Targeted Protein Degradation (TPD) therapeutics for…
Read More...

SQZ Biotechnologies focused on unlocking the full potential of cell therapies for multiple therapeutic areas, announced that the U.S. Food and Drug Administration (FDA) has granted Fast…
Read More...

Serenity Bioworks announces it has completed the acquisition of DC-TAB, a recombinant human HspB5 that was previously in clinical development for relapse-remitting multiple sclerosis.…
Read More...

Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd. announced that the European Commission (EC) has granted marketing authorization for VYDURA (rimegepant), a calcitonin…
Read More...

Daiichi Sankyo and AstraZeneca’s ENHERTU (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the U.S. for the treatment of adult patients with…
Read More...

RVAC Medicines Pte. Ltd. an emerging messenger RNA (mRNA) platform company incubated in Singapore by CBC Group ("CBC"), announced the completion of its series B financing, bringing the…
Read More...

Castle Biosciences, Inc. announced that it has completed its acquisition of AltheaDx, Inc. (AltheaDx). AltheaDx is a commercial-stage molecular diagnostics company specializing in the…
Read More...

Virpax Pharmaceuticals, Inc. a company specializing in developing non-addictive product candidates for pain management, CNS disorders and anti-viral indications, reported preclinical…
Read More...

Pfizer Inc. and BioNTech SE submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of a 10-µg booster dose of the Pfizer-BioNTech…
Read More...